|
序 列 ： |
Human: H-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-OH or H-GSNKGAIIGLM-OH |
| 分 子 式 ： |
C45H81N13O14S1 |
|
分 子 量 ： |
1060.3 g/mol |
|
純 度 ： |
Purity > 95% by HPLC |
|
形 態(tài) ： |
Each vial contains 2 mg of lyophilized solid packaged under an inert gas and supplied as a trifluoroacetate salt. |
|
溶 解： |
We recommend using 100% dimethyl sulfoxide (DMSO). Alternatively, hexafluoroisopropanol (HFIP) can be used. |
|
保存條件 ： |
Store at -20°C. The product is hygroscopic and must be protected from light. Product is guaranteed one year from the date of shipment. Following reconstitution, aliquot and store at -20°C. |
| 產(chǎn)品鏈接 ： |
http://www.ABBIOTEC.com/peptides/beta-amyloid-%25255B25-35%25255D |
|
產(chǎn)品說明 ： |
|
| 產(chǎn)品描述 ： |
Beta-amyloid production results from cleavage in the extracellular domain of APP by the beta-secretase (BACE1), which results in the production of the APP C-terminal fragment C99. This fragment is further cleaved by the gamma-secretase at residues 40-42 to produce beta-amyloid 40 and 42 peptides. Beta-amyloid aggregation and neuritic plaque formation are pathologic hallmarks of Alzheimer disease. This peptide corresponds to the human beta-amyloid 25-35 peptide, which induces apoptosis in cells. |
